🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

17 results for “Prime Medicine” Clear

  1. PG-011 nasal spray 0.6%(twice daily)

    Prime Medicine

    Seasonal Allergic Rhinitis

    phase 3 small molecule active

    1 trial

  2. PG-011Gel

    Prime Medicine

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  3. Recommended treatment schedule

    Prime Medicine

    COVID-19

    phase 3 small molecule terminated

    1 trial

  4. Bemarituzumab

    Prime Medicine

    Gastric Cancer

    phase 2 mab completed

    1 trial

  5. FP-1039

    Prime Medicine

    Endometrial Cancers With FGFR2 Mutations

    phase 2 small molecule terminated

    1 trial

  6. FPA008

    Prime Medicine

    Pigmented Villonodular Synovitis

    phase 2 mab completed

    1 trial

  7. PM359

    Prime Medicine

    Chronic Granulomatous Disease

    phase 2 mab active

    1 trial

  8. Pumecitinib Nasal Spray 0.3%

    Prime Medicine

    Seasonal Allergic Rhinitis

    phase 2 small molecule active

    1 trial

  9. Bemarituzumab

    Prime Medicine

    Gastrointestinal Cancer

    phase 1 mab completed

    1 trial

  10. Cabiralizumab

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab completed

    1 trial

  11. FP-1039

    Prime Medicine

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  12. FPA008

    Prime Medicine

    Healthy

    phase 1 small molecule terminated

    1 trial

  13. FPA144

    Prime Medicine

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  14. FPA150

    Prime Medicine

    Breast Cancer

    phase 1 mab terminated

    1 trial

  15. FPT155

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab terminated

    1 trial

  16. PG-033

    Prime Medicine

    Lichen Simplex Chronicus

    phase 1 small molecule active

    1 trial

  17. Artificial intelligence in diagnosis

    Prime Medicine

    Artificial Intelligence (AI) in Diagnosis

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources